Novartis Kymriah wins UK backing after initial lymphoma snub Medical Dialogues Bureau3 Feb 2019 10:00 AM IST"Today's positive announcement regarding access to Kymriah treatment in England and Wales was secured as a result of our close working collaboration...
Novartis sees 2019 growth as it sheds eyecare unit, narrows focus Garima30 Jan 2019 9:00 AM ISTNovartis said sales of its Entresto heart failure medicine accelerated along with revenue from its psoriasis-and-arthritis blockbuster...
Novartis Aimovig not cost effective: UK price watchdog Medical Dialogues Bureau11 Jan 2019 9:00 AM ISTNovartis, whose U.K. price for Aimovig is about 5,000 pounds ($6,374) annually but which was offering discounts, is counting on the medicine to be a...
Eli Lilly to acquire Loxo Oncology for $8 billion Medical Dialogues Bureau8 Jan 2019 12:09 PM ISTWashington: -Pharmaceutical giant Eli Lilly will acquire cancer treatment specialist Loxo Oncology in a cash deal valued at around $8 billion, the...
Novartis signs deal with Gan & Lee as US government seeks to slash insulin cost Medical Dialogues Bureau30 Dec 2018 9:20 AM ISTZURICH: Swiss drugmaker Novartis aims to become a big player in supplying insulin to swelling numbers of diabetics, signing a deal with China's Gan...
Novartis to buy France's CellforCure to boost cell, gene therapy Medical Dialogues Bureau24 Dec 2018 9:00 AM ISTNovartis, which already has an agreement with CellforCure to help make Kymriah, said it aims to add CellforCure's facilities to a similar factory in...
New Rhein Healthcare announces first closing of its inaugural fund Medical Dialogues Bureau22 Dec 2018 9:00 AM ISTNew Rhein fund closed on $47.7 million of commitments with an additional $15 million commitment to be automatically released upon achieving a targeted...
Novartis to launch epinephrine-rival to EpiPens Farhat Nasim7 Dec 2018 9:30 AM ISTNew Delhi: Novartis AG said its U.S. unit Sandoz Inc will launch Adamis Pharmaceuticals Corp's emergency allergy shots next year in the United States,...
Pfizer to raise US drug prices in January after previously backing down under Trump pressure Medical Dialogues Bureau19 Nov 2018 1:14 PM ISTNEW YORK: Pfizer Inc has recently announced that it plans to hike U.S. prices on 41 of its medicines in January, after walking back its previous...
Alcon, Eye Care Unit of Novartis picks Geneva over Texas for new HQ Medical Dialogues Bureau13 Sept 2018 9:21 AM ISTZURICH: The headquarters of Alcon, the eye care unit of Novartis which will be spun off to shareholders in 2019, will move from the division's...
FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients Medical Dialogues Bureau12 May 2018 12:00 PM ISTThe U.S. Food and Drug Administration today approved Gilenya (fingolimod) to treat relapsing multiple sclerosis (MS) in children and adolescents age...
AstraZeneca's three in one inhaler helps COPD patients in trial Medical Dialogues Bureau30 Jan 2018 9:45 AM ISTAstraZeneca said an inhaler for chronic obstructive pulmonary disease delivered improved lung function in a late-stage trial that could challenge...
